You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.
In Nature this week: genome-wide association study of 42 diseases among Japanese population, transfer RNA modifications, and more.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.
In PLOS this week: improved imputation, evolution of Vibrio cholerae isolates from recent outbreak, and more.
In PNAS this week: emerging songbird pathogen Mycoplasma gallisepticum, CRISPR-Cas9-based knockdown finds role for lipoprotein transport in viability, and more.
In PLOS this week: single protein identification method, Vibrio cholerae sequences from spotted filter paper, and more.
Researchers found a potential alternative toxin, as well as antibiotic resistance genes, in a newly-sequenced Vibrio cholerae strain from a British WWI soldier.
In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.
OmniVis is developing the assay for cholera detection in environmental samples while the lab that created it is working toward a paper-based HIV test.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.